More on ASMB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $20.57 |
|
|||
| Open | $20.63 | ||||
| 52 Wk High | $14.50 | ||||
| 52 Wk Low | $4.33 | ||||
| Day High | $20.63 | ||||
| Day Low | $19.94 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 167,736 | ||||
- Assembly Bio to present Phase 1a data for ABI-6250 at AASLD 2026
- Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
- Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
- Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
- Assembly Bio exercises U.S. profit-share option with Gilead for herpes program
- Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
- UBS Starts Assembly Biosciences (ASMB) at Buy
- Assembly Biosciences (ASMB) PT Lowered to $45 at Mizuho
- Form S-8 ASSEMBLY BIOSCIENCES,
- H.C. Wainwright Reiterates Buy Rating on Assembly Biosciences (ASMB)
Entities mentioned with ASMB
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- FDA | View Related Stories »
- William Blair | View Related Stories »
- Robert W Baird | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
